BridgeBio Pharma to Participate in February and March Investor Events

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO), a biopharmaceutical company, announced participation in several investor conferences in February and March 2023. Key events include the SVB Securities Global Biopharma Conference on February 14 at 2:20 PM ET, the Goldman Sachs Bus Tour on March 1 at 8:00 AM PT, and the Cowen 43rd Annual Healthcare Conference on March 8 at 10:30 AM ET.

Live webcasts will be available on the company's website, with replays accessible for 90 days post-event. Founded in 2015, BridgeBio focuses on developing transformative medicines for genetic diseases and cancers.

PALO ALTO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:

• SVB Securities Global Biopharma Conference, Virtual: Tuesday, February 14^th at 2:20 pm ET
• Goldman Sachs Bus Tour, San Francisco, CA: Wednesday, March 1^st at 8:00 am PT
• Cowen 43rd Annual Healthcare Conference, Boston, MA: Wednesday, March 8^th at 10:30 am ET
  

To access the live webcast of BridgeBio’s fireside chats at the SVB Securities Global Biopharma Conference and the Cowen 43^rd Annual Healthcare Conference, please visit the “Events” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter.

BridgeBio Contact:
Vikram Bali
contact@bridgebio.com
(650)-789-8220

FAQ

What investor conferences is BridgeBio participating in during February and March 2023?

BridgeBio will participate in the SVB Securities Global Biopharma Conference on February 14, Goldman Sachs Bus Tour on March 1, and Cowen 43rd Annual Healthcare Conference on March 8, 2023.

What are the dates and times for the BridgeBio investor conferences?

The SVB Securities conference is on February 14 at 2:20 PM ET, Goldman Sachs Bus Tour is on March 1 at 8:00 AM PT, and Cowen conference is on March 8 at 10:30 AM ET.

Where can I watch the live webcasts of BridgeBio's conferences?

Live webcasts for the conferences can be accessed via the Events page in the Investors section on BridgeBio's website.

How long will the webcasts for BridgeBio investor conferences be available?

The replays of the webcasts will be available for 90 days following each event.

What does BridgeBio Pharma focus on?

BridgeBio Pharma focuses on discovering and developing transformative medicines for genetic diseases and cancers.